// App-Quantinova.ai

1139-097 : BIVALIRUDIN VERSUS UNFRACTIONED HEPARIN: DIFFERENTIAL BENEFIT ACROSS THE SPECTRUM OF PATIENTS RECEIVING PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES

Researchers

Presenter

  • Mohamed Farag

Principal Investigators

  • Diana Gorog

  • Manivannan Srinivasan

Medical Centers

  • Postgraduate Medical School, University of Hertfordshire, Hertfordshire, United Kingdom

  • Department of Cardiology, East and North Hertfordshire NHS Trust, Hertfordshire, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • Glycosylphosphatidylinositol

Drug/Treatment

  • Heparin

  • Bivalirudin

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved